Primary hepatobiliary cancers (PHCs), which mainly include hepatocellular carcinoma
(HCC) and biliary tract cancers (BTCs), are mostly diagnosed in the advanced stage and are …

Chemotherapy remains an important approach for the treatment of liver metastases from
uveal melanoma (UM). Compared with systemic chemotherapy, regional chemotherapy has …

Purpose We aimed to explore the curative effects of hepatic arterial infusion chemotherapy
(HAIC) combined with Tislelizumab and Lenvatinib on unresectable hepatocellular …

Background: Surgery, chemotherapy, and radiation often have limited utility for advanced
metastatic disease in the liver, and despite its promising activity in select cancers, PD-1 …

Background: Hepatic artery infusion chemotherapy (HAI) has been proposed as a valuable
adjunct for multimodal therapy of primary and secondary liver malignancies. This review …

Implementation of a successful hepatic artery infusion pump program requires numerous
factors to be in place, and the lack of any of these may lead to program failure. First and …

ABSTRACT Background and Objectives Hepatic artery infusion pump (HAIP) therapy is an
available option at highly specialized centers to treat unresectable liver tumors (eg …

Abstract Background Discontinuation of the Codman 3000 pump in 2018 left no Food and
Drug Administration (FDA)-approved hepatic artery infusion (HAI) device for unresectable …

Hepatic artery infusion (HAI) delivers localized high-dose floxuridine directly to liver tumors
through an implanted pump. While patients are undergoing active treatment, the pump is …

Combined hepatic artery infusion (HAI) and systemic chemotherapy have demonstrated its
clinical efficacy in prolonging overall survival in unresectable intrahepatic …